Population-based epidemiologic analysis of acute pyelonephritis.
about
Klebsiella pneumoniae: Going on the Offense with a Strong DefenseDuration of antibiotic treatment for acute pyelonephritis and septic urinary tract infection-- 7 days or less versus longer treatment: systematic review and meta-analysis of randomized controlled trialsTreatment duration of febrile urinary tract infection (FUTIRST trial): a randomized placebo-controlled multicenter trial comparing short (7 days) antibiotic treatment with conventional treatment (14 days)Emergence of and risk factors for ciprofloxacin-gentamicin-resistant Escherichia coli urinary tract infections in a region of Quebec.The Most Frequent Isolates from Outpatients with Urinary Tract InfectionWaging war against uropathogenic Escherichia coli: winning back the urinary tractS100A8/A9 is not involved in host defense against murine urinary tract infection.Vitamin D induction of the human antimicrobial Peptide cathelicidin in the urinary bladder.Role of newer and re-emerging older agents in the treatment of infections caused by carbapenem-resistant Enterobacteriaceae.Virulence genotype and phylogenetic groups in relation to Chinese herb resistance among Escherichia coli from patients with acute pyelonephritis.Microbiology of urinary tract infections in Gaborone, Botswana.Clinical and epidemiological features and prognosis of complicated pyelonephritis: a prospective observational single hospital-based study.Perianal Abscess and Proctitis by Klebsiella pneumoniae.Change of antimicrobial susceptibility among Escherichia coli strains isolated from female patients with community-onset acute pyelonephritis.Antibiotic resistance patterns of bacteria causing urinary tract infections in the elderly living in nursing homes versus the elderly living at home: an observational study.Similar Neutrophil-Driven Inflammatory and Antibacterial Responses in Elderly Patients with Symptomatic and Asymptomatic BacteriuriaComparative effectiveness of different oral antibiotics regimens for treatment of urinary tract infection in outpatients: an analysis of national representative claims databaseRapid antimicrobial susceptibility determination of uropathogens in clinical urine specimens by use of ATP bioluminescence.Uncomplicated Urinary Tract Infections in Women in a Sao Paulo Quaternary Care Hospital: Bacterial Spectrum and Susceptibility PatternsThreading the Needle: Small-Molecule Targeting of a Xenobiotic Receptor to Ablate Escherichia coli Polysaccharide Capsule Expression Without Altering Antibiotic Resistance.Treatment outcomes of oral sitafloxacin in acute complicated urinary tract infection and pyelonephritis.Comparison of computed tomography findings between bacteremic and non-bacteremic acute pyelonephritis due to Escherichia coli.Levofloxacin in the treatment of complicated urinary tract infections and acute pyelonephritis.Etiology and antibiotic susceptibility of bacterial pathogens responsible for community-acquired urinary tract infections in Poland.Urinary tract infections in women with type 1 diabetes mellitus: survey of female participants in the epidemiology of diabetes interventions and complications study cohort.Retrospective Comparison of Clinical Characteristics and In-Hospital Outcomes among Diabetic and Non-Diabetic Adults with Acute Pyelonephritis.Transient Proteotoxicity of Bacterial Virulence Factor Pyocyanin in Renal Tubular Epithelial Cells Induces ER-Related Vacuolation and Can Be Efficiently Modulated by Iron Chelators.Usefulness of Blood Cultures and Radiologic Imaging Studies in the Management of Patients with Community-Acquired Acute Pyelonephritis.Pyelonephritis: what are the present day causative organisms and antibiotic susceptibilities?Levofloxacin for the treatment of pyelonephritis.Non-surgical management of recurrent urinary tract infections in womenTreatment of Staphylococcus aureus Infections.Is 5 days of oral fluoroquinolone enough for acute uncomplicated pyelonephritis? The DTP randomized trial.Partial Purification and Characterization of a Bacteriocin DT24 Produced by Probiotic Vaginal Lactobacillus brevis DT24 and Determination of its Anti-Uropathogenic Escherichia coli Potential.Predictors of admission in patients presenting to the emergency department with urinary tract infection.Follow-up of acute pyelonephritis: what causes the diffusion-weighted magnetic resonance imaging recovery to lag clinical recovery?Predictive model of urinary tract infection after surgical treatment for women with endometrial cancer.Severe peri-renal sepsis in established renal failure masquerading as an acute abdominal catastrophe.Risk factors that influence the empirical treatment of patients with acute pyelonephritis: a cohort study.Clinical utility of FDG PET/CT in acute complicated pyelonephritis-results from an observational study.
P2860
Q26745802-57CB74D3-81D7-4F10-8657-35AD0B9CC166Q27003126-E97D629D-85AF-48FB-B969-4EFC0F098BCBQ33494958-F48F66D0-BA0B-4204-8E9F-DAA19ADD2012Q33593668-FC0639ED-A2E4-43AC-B758-848FFB408977Q33594582-930A9D87-A706-47F0-BBED-A154E49FB63BQ33613902-AA9878E4-4786-46BE-A7AB-A06C8E2B3F32Q33728598-CE1B3819-BFA7-4D4F-9DAA-E0AA07613F93Q33778591-A237B008-D91F-4CCD-80F4-95823F41B3D7Q33816251-5827C305-E378-41B8-A84F-3EC3BB26E7C5Q34367387-D16DD6DE-E890-4913-9525-91DE2EE2CDBEQ34613288-DB8F3F1E-E423-4459-B8DC-B28615E3050AQ34710133-39DA5D5C-F2D1-4684-AA6A-0D44A20608C2Q35046225-88F91922-2290-47D6-A7A5-4839FB94C8AFQ35648288-B8A970E6-F230-4039-B71A-698E38C4BB30Q35735584-2BE3BB85-3E32-422A-8BCC-88F33386DD16Q36053469-8B2A1120-905C-430C-A9EC-C6ED6FBA7093Q36153920-94D7F613-790F-4F4A-8976-01F964DA6173Q36539771-8D711C8A-ECC4-48BE-AA0F-8AFD729795B8Q36683610-E399570F-589A-4CA0-BD14-BE8A7E7E9629Q36705848-6B888A7D-B1A6-4B6F-897A-9399203E39ABQ36768202-C46C89F0-511F-4DF5-95AA-4BECBA264774Q36823628-087B317D-F52A-417C-87D5-FD0565AA5C7FQ37052814-B99C2587-2507-4B78-B3B1-6789DEE1A41BQ37099310-C88C6797-A752-4A65-BDA0-21E41CC41855Q37235604-448971E7-737F-4204-9F5F-861D08506E95Q37435539-687B4390-9E09-4843-92F7-3ACD0D5D9509Q37476514-429ED112-19A9-49F1-899C-E2AB1E66B894Q37739002-19530DE7-5E2E-47B4-93EB-B58CE618E421Q38097876-FA829B67-8BE5-4502-8AF9-D2FCFB77A8D2Q38101380-FF5D9FE1-99DE-4387-8CE1-10473182F777Q38632929-C9E5D20A-79F9-42AE-94C7-8B563C921858Q40049973-D2D99A43-BD2D-4454-898D-66C1BCCB36ACQ40065737-23C263BC-B8DF-454C-A59C-05989445CBFEQ40091442-30C2C74F-C3FF-4CB8-B709-196F1E11FE06Q40140131-198F1ADD-3A5E-47A5-B407-73C9AF06916EQ40153953-0FB5DFDD-5F5A-476E-8BBF-04CEA7FC8336Q40161042-7F804A48-EEC0-4E1F-B4CF-DB0E4FC04F91Q40328813-C009516D-D288-478D-884F-B2BE1EB8494CQ41991746-5E6E84D5-9F65-44E2-8CD3-15ADD60BD7F9Q41993794-F199FD04-A9F3-4E6B-916B-754FE3640FA1
P2860
Population-based epidemiologic analysis of acute pyelonephritis.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Population-based epidemiologic analysis of acute pyelonephritis.
@ast
Population-based epidemiologic analysis of acute pyelonephritis.
@en
Population-based epidemiologic analysis of acute pyelonephritis.
@nl
type
label
Population-based epidemiologic analysis of acute pyelonephritis.
@ast
Population-based epidemiologic analysis of acute pyelonephritis.
@en
Population-based epidemiologic analysis of acute pyelonephritis.
@nl
prefLabel
Population-based epidemiologic analysis of acute pyelonephritis.
@ast
Population-based epidemiologic analysis of acute pyelonephritis.
@en
Population-based epidemiologic analysis of acute pyelonephritis.
@nl
P2093
P2860
P356
P1476
Population-based epidemiologic analysis of acute pyelonephritis.
@en
P2093
Christopher A Czaja
Delia Scholes
Thomas M Hooton
Walter E Stamm
P2860
P304
P356
10.1086/519268
P407
P577
2007-06-19T00:00:00Z